...
首页> 外文期刊>Epigenetics: official journal of the DNA Methylation Society >The ZNF217 oncogene is a candidate organizer of repressive histone modifiers.
【24h】

The ZNF217 oncogene is a candidate organizer of repressive histone modifiers.

机译:ZNF217癌基因是抑制性组蛋白修饰剂的候选组织者。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The zinc finger protein 217 (ZNF217) is an important oncogene based on the high frequency of amplification and overexpression in many cancer types, but its molecular mode of gene regulation is poorly understood. We purified a complex of nuclear ZNF217-binding proteins by affinity chromatography and identified its components by mass spectrometry as Jarid1b/Plu-1, G9a, LSD1, CoREST and CtBP1. Individual binding of these with ZNF217 was confirmed by co-immunoprecipiation (IP). Known activities of these proteins suggested a role of the ZNF217 complex in histone modification. Using in vitro assays the following activities were demonstrated: Histone H3 lysine 4 trimethyl (H3K4me3) demethylase activity, which co-fractionated with Jarid1b/Plu-1 in anion-exchange chromatography; H3K9 methylation, the known principal activity of G9a; and H3K27 methylation. The latter suggested EZH2 as another ZNF217 binding candidate, which could be confirmed by co-IP. Taken together, these findings suggest that ZNF217 assembles a distinct set of histone modifying proteins at target DNA sites that act synergistically in transcriptional repression.
机译:锌指蛋白217(ZNF217)是一种重要的癌基因,基于许多癌症类型中扩增和过度表达的高频率,但是人们对其基因调控的分子模式了解甚少。我们通过亲和色谱纯化了核ZNF217结合蛋白复合物,并通过质谱鉴定了其成分,如Jarid1b / Plu-1,G9a,LSD1,CoREST和CtBP1。通过共免疫沉淀(IP)证实了它们与ZNF217的单独结合。这些蛋白质的已知活性表明ZNF217复合物在组蛋白修饰中的作用。使用体外试验证明了以下活性:组蛋白H3赖氨酸4三甲基(H3K4me3)脱甲基酶活性,在阴离子交换色谱中与Jarid1b / Plu-1共分馏; H3K9甲基化,已知的G9a主要活性;和H3K27甲基化。后者提示EZH2是另一种ZNF217结合候选物,这可以通过co-IP确认。综上所述,这些发现表明ZNF217在靶DNA位点组装了一组独特的组蛋白修饰蛋白,这些蛋白在转录抑制中起协同作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号